See more : Zicom Electronic Security Systems Limited (ZICOM.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Humana Inc. (HUM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Humana Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
- Quantum FinTech Acquisition Corporation (QFTA-UN) Income Statement Analysis – Financial Results
- NextFerm Technologies Ltd (NXFR.TA) Income Statement Analysis – Financial Results
- Nissan Chemical Corporation (NNCHY) Income Statement Analysis – Financial Results
- Lincoln Pharmaceuticals Limited (LINCOPH.BO) Income Statement Analysis – Financial Results
- Kurashicom Inc. (7110.T) Income Statement Analysis – Financial Results
Humana Inc. (HUM)
About Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 106.37B | 92.87B | 83.06B | 77.16B | 64.89B | 56.91B | 53.77B | 54.38B | 54.29B | 48.50B | 41.31B | 39.13B | 36.83B | 33.87B | 30.96B | 28.95B | 25.29B | 21.42B | 14.42B | 13.10B | 12.23B | 11.26B | 10.19B | 10.51B | 10.11B | 9.78B | 8.04B | 6.79B | 4.70B | 3.65B | 3.14B | 4.04B | 5.87B | 4.85B |
Cost of Revenue | 13.19B | 12.67B | 10.12B | 10.05B | 7.38B | 7.53B | 6.57B | 7.28B | 7.32B | 7.64B | 6.36B | 5.83B | 5.40B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 93.19B | 80.20B | 72.94B | 67.10B | 57.51B | 49.39B | 47.20B | 47.10B | 46.97B | 40.86B | 34.96B | 33.30B | 31.44B | 33.87B | 30.96B | 28.95B | 25.29B | 21.42B | 14.42B | 13.10B | 12.23B | 11.26B | 10.19B | 10.51B | 10.11B | 9.78B | 8.04B | 6.79B | 4.70B | 3.65B | 3.14B | 4.04B | 5.87B | 4.85B |
Gross Profit Ratio | 87.60% | 86.36% | 87.82% | 86.97% | 88.63% | 86.78% | 87.79% | 86.62% | 86.52% | 84.25% | 84.62% | 85.10% | 85.35% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.40B | 4.66B | 4.23B | 3.94B | 3.48B | 3.02B | 2.18B | 1.88B | 1.86B | 1.74B | 1.55B | 1.44B | 1.37B | 1.33B | 1.12B | 940.00M | 571.00M | 436.00M | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 12.20B | 10.12B | 10.05B | 7.38B | 7.53B | 6.42B | 7.17B | 7.30B | 7.64B | 6.36B | 5.83B | 5.40B | 4.66B | 4.23B | 3.94B | 3.48B | 3.02B | 2.18B | 1.88B | 1.86B | 1.74B | 1.55B | 1.44B | 1.37B | 1.33B | 1.12B | 940.00M | 571.00M | 436.00M | 368.00M | 371.00M | 226.00M | 226.40M |
Other Expenses | 102.36B | 76.87B | 69.20B | 62.15B | 53.80B | 47.10B | 43.09B | 45.47B | 44.38B | 38.50B | 32.90B | 31.28B | 29.09B | 27.08B | 24.81B | 23.93B | 20.46B | 17.57B | 11.80B | 10.79B | 10.01B | -12.77B | 8.44B | 8.93B | -11.85B | -10.86B | -8.86B | -7.70B | -4.97B | -3.81B | -3.36B | -4.11B | -5.44B | -4.48B |
Operating Expenses | 102.36B | 89.07B | 79.32B | 72.20B | 61.18B | 54.62B | 49.51B | 52.64B | 51.67B | 46.14B | 39.25B | 37.11B | 34.49B | 31.74B | 29.04B | 27.87B | 23.93B | 20.59B | 13.98B | 12.67B | 11.86B | -11.03B | 9.99B | 10.37B | -10.48B | -9.53B | -7.75B | -6.76B | -4.40B | -3.37B | -2.99B | -3.74B | -5.21B | -4.25B |
Cost & Expenses | 102.36B | 89.07B | 79.32B | 72.20B | 61.18B | 54.62B | 49.51B | 52.64B | 51.67B | 46.14B | 39.25B | 37.11B | 34.60B | 32.12B | 29.36B | 27.95B | 24.00B | 20.65B | 14.00B | 12.69B | 11.88B | 11.05B | 10.01B | 10.40B | 10.52B | 9.58B | 7.77B | 6.77B | 4.41B | 3.40B | 422.00M | 680.00M | 579.00M | 568.60M |
Interest Income | 0.00 | 401.00M | 326.00M | 283.00M | 242.00M | 218.00M | 242.00M | 189.00M | 186.00M | 192.00M | 140.00M | 105.00M | 0.00 | 60.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 493.00M | 401.00M | 326.00M | 283.00M | 242.00M | 218.00M | 242.00M | 189.00M | 186.00M | 192.00M | 140.00M | 105.00M | 109.00M | 105.06M | 105.84M | 80.29M | 68.88M | 63.14M | 39.32M | 23.17M | 17.37M | 17.25M | 25.30M | 29.00M | 33.00M | 47.00M | 20.00M | 11.00M | 11.00M | 25.00M | 7.00M | 71.00M | 97.00M | 111.30M |
Depreciation & Amortization | 917.00M | 845.00M | 713.00M | 616.00M | 575.00M | 534.00M | 485.00M | 465.00M | 447.00M | 449.00M | 426.00M | 338.00M | 303.00M | 262.91M | 250.27M | 220.35M | 184.81M | 148.60M | 128.86M | 117.79M | 126.78M | 120.73M | 171.02M | 147.00M | 124.00M | 128.00M | 108.00M | 98.00M | 70.00M | 50.00M | 47.00M | 238.00M | 256.00M | 230.90M |
EBITDA | 4.93B | 4.68B | 4.34B | 5.45B | 4.17B | 2.85B | 4.75B | 2.21B | 3.06B | 2.81B | 2.49B | 2.35B | 2.54B | 2.12B | 1.85B | 1.29B | 1.47B | 910.68M | 550.57M | 533.64M | 488.86M | 347.92M | 369.91M | 290.00M | -247.45M | 331.00M | 128.00M | 116.00M | 81.00M | 307.00M | 54.00M | 309.00M | 353.00M | 342.20M |
EBITDA Ratio | 4.63% | 5.00% | 5.37% | 7.22% | 6.61% | 4.97% | 8.83% | 4.06% | 5.64% | 5.80% | 6.02% | 6.02% | 6.89% | 5.94% | 5.98% | 4.19% | 5.83% | 4.25% | 3.82% | 4.07% | 3.86% | 2.94% | 3.47% | 2.48% | -2.77% | 3.38% | 4.70% | 1.71% | 7.61% | 8.40% | 88.05% | 89.07% | 94.49% | 93.04% |
Operating Income | 4.01B | 3.80B | 3.75B | 4.96B | 3.71B | 2.29B | 4.26B | 1.74B | 2.62B | 2.36B | 2.06B | 2.02B | 2.24B | 1.75B | 1.60B | 992.85M | 1.29B | 762.09M | 421.71M | 415.85M | 344.72M | 209.93M | 183.08M | 114.00M | -404.00M | 203.00M | 270.00M | 18.00M | 288.00M | 257.00M | 2.72B | 3.36B | 5.29B | 4.28B |
Operating Income Ratio | 3.77% | 4.09% | 4.51% | 6.42% | 5.72% | 4.03% | 7.93% | 3.20% | 4.82% | 4.87% | 4.99% | 5.15% | 6.07% | 5.17% | 5.17% | 3.43% | 5.10% | 3.56% | 2.92% | 3.17% | 2.82% | 1.86% | 1.80% | 1.08% | -3.99% | 2.08% | 3.36% | 0.27% | 6.13% | 7.03% | 86.55% | 83.18% | 90.13% | 88.28% |
Total Other Income/Expenses | -630.00M | -232.00M | -391.00M | -386.00M | 264.00M | -1.04B | -242.00M | -189.00M | 84.00M | -192.00M | -140.00M | -105.00M | 5.29B | -105.06M | -105.84M | -80.29M | -68.69M | -63.45M | -20.41M | -23.17M | 0.00 | 0.00 | 0.00 | 0.00 | -404.84M | 203.08M | 0.00 | 0.00 | 0.00 | 257.00M | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax | 3.38B | 3.57B | 3.35B | 4.60B | 3.46B | 2.06B | 4.02B | 1.55B | 2.43B | 2.17B | 1.92B | 1.91B | 2.24B | 1.75B | 1.60B | 992.85M | 1.29B | 762.09M | 421.71M | 415.85M | 344.72M | 209.93M | 183.08M | 114.00M | -404.00M | 203.00M | 270.00M | 18.00M | 288.00M | 257.00M | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | 3.18% | 3.84% | 4.04% | 5.96% | 5.33% | 3.62% | 7.48% | 2.85% | 4.48% | 4.47% | 4.65% | 4.88% | 6.07% | 5.17% | 5.17% | 3.43% | 5.10% | 3.56% | 2.92% | 3.17% | 2.82% | 1.86% | 1.80% | 1.08% | -3.99% | 2.08% | 3.36% | 0.27% | 6.13% | 7.03% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 836.00M | 762.00M | 485.00M | 1.31B | 763.00M | 391.00M | 1.57B | 938.00M | 1.16B | 1.02B | 690.00M | 689.00M | 816.00M | 650.17M | 562.09M | 345.69M | 455.62M | 274.66M | 113.23M | 135.84M | 115.78M | 67.18M | 65.91M | 24.00M | -22.00M | 74.00M | 97.00M | 6.00M | 98.00M | 81.00M | 54.00M | 109.00M | 200.00M | 180.50M |
Net Income | 2.49B | 2.81B | 2.93B | 3.37B | 2.71B | 1.68B | 2.45B | 614.00M | 1.28B | 1.15B | 1.23B | 1.22B | 1.42B | 1.10B | 1.04B | 647.15M | 833.68M | 487.42M | 308.48M | 280.01M | 228.93M | 142.76M | 117.17M | 90.00M | -382.00M | 129.00M | 173.00M | 12.00M | 190.00M | 176.00M | 89.00M | 122.70M | 355.00M | 309.60M |
Net Income Ratio | 2.34% | 3.02% | 3.53% | 4.36% | 4.17% | 2.96% | 4.55% | 1.13% | 2.35% | 2.36% | 2.98% | 3.12% | 3.85% | 3.25% | 3.36% | 2.24% | 3.30% | 2.28% | 2.14% | 2.14% | 1.87% | 1.27% | 1.15% | 0.86% | -3.78% | 1.32% | 2.15% | 0.18% | 4.04% | 4.82% | 2.84% | 3.03% | 6.05% | 6.38% |
EPS | 20.09 | 22.20 | 22.79 | 25.47 | 20.20 | 12.24 | 16.94 | 4.11 | 8.54 | 7.44 | 7.81 | 7.56 | 8.58 | 6.55 | 6.21 | 3.87 | 5.00 | 2.97 | 1.91 | 1.75 | 1.41 | 0.85 | 0.71 | 0.54 | -2.28 | 0.77 | 1.06 | 0.07 | 1.17 | 1.10 | 0.56 | 0.77 | 2.26 | 3.00 |
EPS Diluted | 20.00 | 22.08 | 22.67 | 25.31 | 20.10 | 12.16 | 16.81 | 4.07 | 8.44 | 7.36 | 7.73 | 7.47 | 8.46 | 6.47 | 6.15 | 3.83 | 4.91 | 2.90 | 1.87 | 1.72 | 1.38 | 0.83 | 0.70 | 0.54 | -2.28 | 0.77 | 1.05 | 0.07 | 1.16 | 1.10 | 0.55 | 0.77 | 2.26 | 3.00 |
Weighted Avg Shares Out | 123.87M | 126.42M | 128.69M | 132.20M | 134.05M | 137.49M | 144.49M | 149.37M | 149.45M | 154.19M | 157.50M | 161.48M | 165.41M | 167.78M | 167.36M | 167.17M | 166.87M | 164.12M | 161.51M | 160.01M | 158.68M | 167.95M | 165.03M | 166.76M | 167.73M | 167.48M | 163.41M | 162.53M | 162.27M | 160.00M | 158.93M | 159.35M | 157.08M | 101.13M |
Weighted Avg Shares Out (Dil) | 124.44M | 127.09M | 129.40M | 133.01M | 134.73M | 138.40M | 145.58M | 150.92M | 151.14M | 155.87M | 159.15M | 163.46M | 167.83M | 169.80M | 169.07M | 168.97M | 169.82M | 168.08M | 164.96M | 162.80M | 162.13M | 171.99M | 167.39M | 166.76M | 167.73M | 167.48M | 165.84M | 165.28M | 164.59M | 160.79M | 161.82M | 159.35M | 157.08M | 101.13M |
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
Humana Recognized for Commitment to Veteran Employment by Military Times and Military Friendly®
2 Healthcare Stocks in Focus After Merger Talks Break Down
Humana Stock Slumps as Cigna Says It's Not Pursuing Combination
Cigna rallies after Humana mega-merger called off
Humana Stock Tumbles. Cigna Won't Pursue the Health Insurer.
Cigna says it will not pursue combination with Humana
Source: https://incomestatements.info
Category: Stock Reports